Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
8.0
4.5
Journals
Cancers
Special Issues
Precision Medicine in Breast Cancer: From Epidemiology to Cancer Prevention,...
share announcement

Precision Medicine in Breast Cancer: From Epidemiology to Cancer Prevention, Screening and Early Detection

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Epidemiology and Prevention".

Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 7244

Special Issue Editor

Dr. Anne Marie McCarthy

E-Mail Website
Guest Editor
Department of Biostatistics, Epidemiology & Informatics, University of Pennsylvania, Philadelphia, PA 19104, USA
Interests: cancer epidemiology; cancer disparities; cancer prevention; screening and early detection; genetic testing; breast cancer; cancer genomics; precision medicine

Special Issue Information

Dear Colleagues,

A large body of literature heralds the potential benefits of precision medicine—a paradigm that uses individual variation in genes, environment, and lifestyle to improve disease prevention, diagnosis, and treatment. Breast cancer has been at the forefront of precision medicine. However, precision medicine approaches to breast cancer prevention have lagged behind advances in treatment. Expanding our ability to tailor and implement effective preventive interventions is necessary to fully realize the promise of precision medicine for public health. We are pleased to invite you to submit a manuscript for this Special Issue on breast cancer precision medicine as it relates to cancer prevention, screening, and early detection. This Special Issue aims to showcase epidemiological, clinical, and translational research that moves the field toward the precision prevention of breast cancer. Research areas may include (but are not limited to) the following: improved risk assessment tools, novel biomarkers of risk, chemoprevention, genetic susceptibility, impact of precision medicine on health disparities, relevant data integration and analytic methods, and the implementation of precision prevention strategies. In this Special Issue, original research articles and reviews are welcome. We look forward to receiving your contributions.

Dr. Anne Marie McCarthy
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • breast cancer
  • precision medicine
  • precision prevention
  • personalized screening
  • screening
  • early detection
  • risk assessment
  • biomarkers
  • genetic susceptibility

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (3 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

14 pages, 1801 KiB  
Article
A Rare Variant in MDH2 (rs111879470) Is Associated with Predisposition to Recurrent Breast Cancer in an Extended High-Risk Pedigree
by Lisa A. Cannon-Albright, Jeff Stevens, Craig C. Teerlink, Julio C. Facelli, Kristina Allen-Brady and Alana L. Welm
Cancers 2023, 15(24), 5851; https://doi.org/10.3390/cancers15245851 - 15 Dec 2023
Cited by 2 | Viewed by 1747
Abstract
A significant fraction of breast cancer recurs, with lethal outcome, but specific genetic variants responsible have yet to be identified. Five cousin pairs with recurrent breast cancer from pedigrees with a statistical excess of recurrent breast cancer were sequenced to identify rare, shared [...] Read more.
A significant fraction of breast cancer recurs, with lethal outcome, but specific genetic variants responsible have yet to be identified. Five cousin pairs with recurrent breast cancer from pedigrees with a statistical excess of recurrent breast cancer were sequenced to identify rare, shared candidate predisposition variants. The candidates were tested for association with breast cancer risk with UKBiobank data. Additional breast cancer cases were assayed for a subset of candidate variants to test for co-segregation. Three-dimensional protein structure prediction methods were used to investigate how the mutation under consideration is predicted to change structural and electrostatic properties in the mutated protein. One hundred and eighty-one rare candidate predisposition variants were shared in at least one cousin pair from a high-risk pedigree. A rare variant in MDH2 was found to segregate with breast-cancer-affected relatives in one extended pedigree. MDH2 is an estrogen-stimulated gene encoding the protein malate dehydrogenase, which catalyzes the reversible oxidation of malate to oxaloacetate. The molecular simulation results strongly suggest that the mutation changes the NAD+ binding pocket electrostatics of MDH2. This small sequencing study, using a powerful approach based on recurrent breast cancer cases from high-risk pedigrees, identified a set of strong candidate variants for inherited predisposition for breast cancer recurrence, including MDH2, which should be pursued in other resources. Full article
(This article belongs to the Special Issue Precision Medicine in Breast Cancer: From Epidemiology to Cancer Prevention, Screening and Early Detection)
►▼ Show Figures

Figure 1

12 pages, 530 KiB  
Article
Choice of Assessment and Subsequent Risk of Breast Cancer among Women with False-Positive Mammography Screening
by Bayan Sardini, Susanne Fogh Jørgensen, Lisbet Brønsro Larsen, Mohammad Talal Elhakim and Sisse Helle Njor
Cancers 2023, 15(6), 1867; https://doi.org/10.3390/cancers15061867 - 20 Mar 2023
Cited by 1 | Viewed by 2175
Abstract
Women with false-positive mammography screening results have a two- to four-fold higher risk of breast cancer. This study aimed to investigate if the subsequent risk of breast cancer after a false-positive mammography screening is associated with the received diagnostic assessment. The study population [...] Read more.
Women with false-positive mammography screening results have a two- to four-fold higher risk of breast cancer. This study aimed to investigate if the subsequent risk of breast cancer after a false-positive mammography screening is associated with the received diagnostic assessment. The study population consisted of women who underwent false-positive mammography screening from January 2010 to June 2019. They were categorised into seven groups depending on the elements in the assessment (standard care: additional mammography, ultrasound, and if they had a relevant biopsy). Risks of interval cancer, next-round screen-detected cancer, and long-term breast cancer for non-standard care assessments were compared to standard care assessments using Binomial and Cox regression models. We included 44,279 women with a false-positive result. Invasive assessments that lacked an ultrasound or additional mammography were not more associated with an increased risk of subsequent cancers compared to that of ‘all three elements’. The few assessments that included ‘only ultrasound’ or ‘only mammography’ resulted in higher relative risks of next-round screen-detected cancer of 1.52 (95% CI: 0.93–2.47) and 1.67 (95% CI: 0.54–5.16), respectively, compared to that of standard care. The increased subsequent risk of breast cancer among women with a previous false-positive result was not found to be correlated with the choice of elements in the assessment process. Full article
(This article belongs to the Special Issue Precision Medicine in Breast Cancer: From Epidemiology to Cancer Prevention, Screening and Early Detection)
►▼ Show Figures

Figure 1

18 pages, 2082 KiB  
Article
Factors Influencing Residual Glandular Breast Tissue after Risk-Reducing Mastectomy in Genetically Predisposed Individuals Detected by MRI Mammography
by Frederic Dietzel, Leoni Kolberg, Anne Sophie Vesper, Jürgen Hoffmann, Carolin Nestle-Krämling, Karin Zwiefel, Verena Friebe, Lino M. Sawicki, Nils Martin Bruckmann, Kai Jannusch, Janna Morawitz, Gerald Antoch, Tanja Natascha Fehm, Julian Kirchner and Svjetlana Mohrmann
Cancers 2023, 15(3), 829; https://doi.org/10.3390/cancers15030829 - 29 Jan 2023
Cited by 6 | Viewed by 2565
Abstract
Purpose: This study seeks to evaluate MR imaging morphological factors and other covariates that influence the presence of residual glandular tissue after risk-reducing mastectomy in patients with a familial predisposition. Methods: We analyzed women of a high-risk collective with pathogenic mutation (BRCA1 (n [...] Read more.
Purpose: This study seeks to evaluate MR imaging morphological factors and other covariates that influence the presence of residual glandular tissue after risk-reducing mastectomy in patients with a familial predisposition. Methods: We analyzed women of a high-risk collective with pathogenic mutation (BRCA1 (n = 49), BRCA2 (n = 24), or further mutation (n = 9)). A total of 117 breasts were analyzed, 63 left and 54 right, from a cohort of 81 patients, who were on average 40 years old. The mean follow-up was 63 months (range 12–180 months, SD = 39.67). Retrospective analysis of MR imaging data from 2006–2022 of patients of a high-risk collective (all carriers of a pathogenic mutation) with contralateral (RRCM) or bilateral risk-reducing mastectomy (RRBM) was performed. In the image data the remaining skin flap thickness by distance measurements at eight equally distributed, clockwise points and the retromamillary area, as well as by volumetry of each breast, was elected. Residual glandular tissue was also volumetrized. In addition, patient-related covariates were recorded and their influence on postoperative residual glandular tissue and skin flap thickness was analyzed by uni- and multivariate regressions. Results: A significant association with postoperative residual glandular tissue was shown in multivariate analysis for the independent variables breast density, skin flap mean, and surgical method (all p-values < 0.01). A negatively significant association could be seen for the variables preoperative breast volume (p-values < 0.01) and surgeon experience (most p-values < 0.05–<0.1). Conclusion: Postoperative residual glandular tissue is an important tool for quantifying the risk of developing breast cancer after risk-reducing mastectomy. Different effects on residual glandular tissue were shown for the independent variables breast density, skin flap, surgical method, preoperative breast volume, and surgeon experience, so these should be considered in future surgical procedures preoperatively as well as postoperatively. Breast MRI has proven to be a suitable method to analyze the skin flap as well as the RGT. Full article
(This article belongs to the Special Issue Precision Medicine in Breast Cancer: From Epidemiology to Cancer Prevention, Screening and Early Detection)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-3
Back to TopTop